Legal & General Group
SCMP

Legal & General Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Legal & General Group’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-44,943
Closed -$807K – 3312
2017
Q4 		$807K Sell
44,943
-2,550
-5% -$31.4K ﹤0.01% 1962
2017
Q3 		$560K Buy
47,493
+2,737
+6% +$30.7K ﹤0.01% 2061
2017
Q2 		$470K Buy
44,756
+3,701
+9% +$37.7K ﹤0.01% 2065
2017
Q1 		$452K Buy
41,055
+34,500
+526% +$400K ﹤0.01% 2058
2016
Q4 		$89K Buy
6,555
+2,124
+48% +$29.6K ﹤0.01% 2634
2016
Q3 		$54K Sell
4,431
-557
-11% -$6.56K ﹤0.01% 2491
2016
Q2 		$54K Hold
4,988
– – ﹤0.01% 2447
2016
Q1 		$52K Hold
4,988
– – ﹤0.01% 2399
2015
Q4 		$86K Hold
4,988
– – ﹤0.01% 2160
2015
Q3 		$98K Hold
4,988
– – ﹤0.01% 2060
2015
Q2 		$82K Buy
+4,988
New +$86.5K ﹤0.01% 2267

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Legal & General Group's SCMP Position: Q1 2018 in Review

Legal & General Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 44,943 shares — an estimated $807K sold.

Legal & General Group first reported a position in SCMP in Q2 2015 and held it in 11 quarters. The position peaked at $807K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Legal & General Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Legal & General Group sold 44,943 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $807K.
  • Legal & General Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2015 and held it in 11 quarters.
  • Legal & General Group's Sucampo Pharmaceuticals, Inc. position peaked at $807K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Legal & General Group's 13F filing for Q1 2018, filed 17 May 2018.